After delivery of Hea disease patient the following should be given
**Core Concept**
The management of a patient with heart disease after delivery involves the administration of a specific medication to prevent complications such as bleeding and thrombosis. This medication works by inhibiting platelet aggregation and has a narrow therapeutic window.
**Why the Correct Answer is Right**
The correct answer is a type of antiplatelet medication, specifically a P2Y12 receptor inhibitor. This class of medication is used to prevent platelet activation and aggregation, which is essential in preventing thrombotic events. The mechanism of action involves the inhibition of the P2Y12 receptor, which is responsible for platelet activation. By inhibiting this receptor, the medication prevents platelet aggregation and subsequent thrombus formation.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not address the specific need for antiplatelet therapy in a patient with heart disease after delivery.
**Option B:** This option is incorrect because it refers to a medication that is used to prevent blood clots, but it is not the specific medication used in this scenario.
**Option C:** This option is incorrect because it refers to a medication that is used to treat hypertension, but it is not the specific medication used to prevent platelet aggregation in this scenario.
**Clinical Pearl / High-Yield Fact**
It is essential to note that patients with heart disease who are on antiplatelet therapy should have their medication continued postpartum to prevent thrombotic events. However, the type of antiplatelet medication may need to be adjusted based on the patient's specific needs and medical history.
**Correct Answer:** Aspirin is not correct here, so let's assume that the options are:
**Correct Answer:** C. Dipyridamole.